Celularity (CELUW) Assets (2018 - 2025)
Celularity (CELUW) reported Assets of $107.3 million for Q4 2025, down 19.11% year-over-year from $132.7 million in Q4 2024, and down 6.05% quarter-over-quarter from $114.2 million in Q3 2025.
Celularity (CELUW) Assets (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 8 years of Assets data on file, last reported at $107.3 million in Q4 2025.
- Assets for Q4 2025 came in at $107.3 million, down 19.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $107.3 million (down 19.11% YoY), and the FY2025 annual result was $107.3 million, down 19.11% from the prior year.
- Assets declined to $107.3 million in Q4 2025 per CELUW's latest filing, from $114.2 million in the prior quarter.
- Over five years, Assets peaked at $448.3 million in Q3 2021 and troughed at $107.3 million in Q4 2025.
- A 5-year average of $245.3 million and a median of $150.5 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2023: Assets soared 234.33% in 2022, then sank 64.12% in 2023.
- A 5-year view of Assets shows it stood at $414.1 million in 2021, then slipped by 3.15% to $401.1 million in 2022, then slumped by 64.12% to $143.9 million in 2023, then dropped by 7.79% to $132.7 million in 2024, then slipped by 19.11% to $107.3 million in 2025.
- Business Quant data shows CELUW's Assets at $107.3 million in Q4 2025, $114.2 million in Q3 2025, and $120.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 107.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 107.33 Mn |
| Sep 30, 2025 | 114.24 Mn |
| Jun 30, 2025 | 120.28 Mn |
| Mar 31, 2025 | 128.88 Mn |
| Dec 31, 2024 | 132.68 Mn |
| Sep 30, 2024 | 128.84 Mn |
| Jun 30, 2024 | 135.49 Mn |
| Mar 31, 2024 | 143.82 Mn |
| Dec 31, 2023 | 143.89 Mn |
| Sep 30, 2023 | 157.19 Mn |
| Jun 30, 2023 | 246.42 Mn |
| Mar 31, 2023 | 362.42 Mn |
| Dec 31, 2022 | 401.07 Mn |
| Sep 30, 2022 | 437.12 Mn |
| Jun 30, 2022 | 429.34 Mn |
| Mar 31, 2022 | 434.20 Mn |
| Dec 31, 2021 | 414.13 Mn |
| Sep 30, 2021 | 448.29 Mn |
| Jun 30, 2021 | 128.42 Mn |
| Mar 31, 2021 | 291.93 Mn |